Boston Partners’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-139,566
Closed -$548K 721
2025
Q1
$548K Sell
139,566
-4,227,785
-97% -$20M ﹤0.01% 621
2024
Q4
$22.2M Sell
4,367,351
-66,100
-1% -$381K 0.03% 322
2024
Q3
$31.5M Buy
4,433,451
+2,462,696
+125% +$15.7M 0.04% 277
2024
Q2
$11.2M Buy
1,970,755
+1,413,259
+254% +$9.01M 0.01% 389
2024
Q1
$4.14M Buy
557,496
+241,292
+76% +$2.02M ﹤0.01% 447
2023
Q4
$2.93M Sell
316,204
-230,467
-42% -$1.7M ﹤0.01% 467
2023
Q3
$3.67M Buy
546,671
+285,881
+110% +$2.28M 0.01% 432
2023
Q2
$2.48M Buy
+260,790
New +$2.21M ﹤0.01% 465

Other funds holding CLVT

Boston Partners's CLVT Position: Q2 2025 in Review

Boston Partners sold out of Clarivate (CLVT) in Q2 2025, closing a stake of 139,566 shares — an estimated $548K sold.

Boston Partners first reported a position in CLVT in Q2 2023 and held it in 8 quarters. The position peaked at $31.5M in Q3 2024. 228 funds tracked by Wall St. Rank hold CLVT as of Q2 2025.

  • Boston Partners reported no remaining Clarivate position as of Q2 2025 after selling out during the quarter.
  • Boston Partners sold 139,566 Clarivate shares in Q2 2025, an estimated $548K.
  • Boston Partners first reported a position in Clarivate in Q2 2023 and held it in 8 quarters.
  • Boston Partners's Clarivate position peaked at $31.5M in Q3 2024.
  • 228 funds tracked by Wall St. Rank held Clarivate as of Q2 2025.

Based on Boston Partners's 13F filing for Q2 2025, filed 7 Aug 2025.